Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Victoria N Parikh

Showing results (21-30 of 69) with videos related to

Pageof 7
Sort By:
Circulation|October 18, 2023
Improved Cardiac Performance and Decreased Arrhythmia in Hypertrophic Cardiomyopathy With Non-β-Blocking R-Enantiomer CarvedilolKinya Seo, Yuta Yamamoto, Anna Kirillova, et al.
Nature Genetics|December 11, 2023
Genetic architecture of cardiac dynamic flow volumesBruna Gomes, Aditya Singh, Jack W O'Sullivan, et al.
Arxiv|July 10, 2023
Minimum information and guidelines for reporting a Multiplexed Assay of Variant EffectMelina Claussnitzer, Victoria N Parikh, Alex H Wagner, et al.
Genome Biology|April 19, 2024
Minimum information and guidelines for reporting a multiplexed assay of variant effectMelina Claussnitzer, Victoria N Parikh, Alex H Wagner, et al.
Nature Reviews. Cardiology|September 1, 2025
Creating an atlas of variant effects to resolve variants of uncertain significance and guide cardiovascular medicineAndrew M Glazer, Daniel R Tabet, Victoria N Parikh, et al.
JAMA Cardiology|January 7, 2026
Social Determinants of Health and Clinical Outcomes in Hypertrophic CardiomyopathyNeha Hafeez, Brian L Claggett, Anjali T Owens, et al.
Circulation|February 29, 2012
MicroRNA-21 integrates pathogenic signaling to control pulmonary hypertension: results of a network bioinformatics approachVictoria N Parikh, Richard C Jin, Sabrina Rabello, et al.
Circulation|July 19, 2019
Allele-Specific Silencing Ameliorates Restrictive Cardiomyopathy Attributable to a Human Myosin Regulatory Light Chain MutationKathia Zaleta-Rivera, Alexandra Dainis, Alexandre J S Ribeiro, et al.
European Heart Journal|September 7, 2021
Worldwide differences in primary prevention implantable cardioverter defibrillator utilization and outcomes in hypertrophic cardiomyopathyVictor Nauffal, Peter Marstrand, Larry Han, et al.
Circulation. Genomic and Precision Medicine|July 2, 2024
Multisite Validation of a Functional Assay to Adjudicate <i>SCN5A</i> Brugada Syndrome-Associated VariantsJoanne G Ma, Matthew J O'Neill, Ebony Richardson, et al.
Pageof 7

Showing results (21-30 of 69) with videos related to

Sort By:
Pageof 7
Circulation|October 18, 2023
Improved Cardiac Performance and Decreased Arrhythmia in Hypertrophic Cardiomyopathy With Non-β-Blocking R-Enantiomer CarvedilolKinya Seo, Yuta Yamamoto, Anna Kirillova, et al.
Nature Genetics|December 11, 2023
Genetic architecture of cardiac dynamic flow volumesBruna Gomes, Aditya Singh, Jack W O'Sullivan, et al.
Arxiv|July 10, 2023
Minimum information and guidelines for reporting a Multiplexed Assay of Variant EffectMelina Claussnitzer, Victoria N Parikh, Alex H Wagner, et al.
Genome Biology|April 19, 2024
Minimum information and guidelines for reporting a multiplexed assay of variant effectMelina Claussnitzer, Victoria N Parikh, Alex H Wagner, et al.
Nature Reviews. Cardiology|September 1, 2025
Creating an atlas of variant effects to resolve variants of uncertain significance and guide cardiovascular medicineAndrew M Glazer, Daniel R Tabet, Victoria N Parikh, et al.
JAMA Cardiology|January 7, 2026
Social Determinants of Health and Clinical Outcomes in Hypertrophic CardiomyopathyNeha Hafeez, Brian L Claggett, Anjali T Owens, et al.
Circulation|February 29, 2012
MicroRNA-21 integrates pathogenic signaling to control pulmonary hypertension: results of a network bioinformatics approachVictoria N Parikh, Richard C Jin, Sabrina Rabello, et al.
Circulation|July 19, 2019
Allele-Specific Silencing Ameliorates Restrictive Cardiomyopathy Attributable to a Human Myosin Regulatory Light Chain MutationKathia Zaleta-Rivera, Alexandra Dainis, Alexandre J S Ribeiro, et al.
European Heart Journal|September 7, 2021
Worldwide differences in primary prevention implantable cardioverter defibrillator utilization and outcomes in hypertrophic cardiomyopathyVictor Nauffal, Peter Marstrand, Larry Han, et al.
Circulation. Genomic and Precision Medicine|July 2, 2024
Multisite Validation of a Functional Assay to Adjudicate <i>SCN5A</i> Brugada Syndrome-Associated VariantsJoanne G Ma, Matthew J O'Neill, Ebony Richardson, et al.
Pageof 7